A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life ResultsRiccardo Soffietti, Andrew Bottomley, Rolf‐Dieter Kortmann et al.|Journal of Clinical Oncology|2012Cited by 645
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancerJane Blazeby, Derek Alderson, Thierry Conroy et al.|European Journal of Cancer|2003Cited by 415
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancerJane Blazeby, Corneel Coens, Thierry Conroy et al.|European Journal of Cancer|2004Cited by 225
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialAndrew Bottomley, Daniil Stroyakovskiy, Corneel Coens et al.|The Lancet Oncology|2021Cited by 72